Figure 1.
Surrogate response biomarkers will guide neoadjuvant treatment. ER, oestrogen receptor; pCR, pathological complete response; PR, progesterone receptor; Rx, treatment.
Fabian Breast Cancer Research 2007 9(Suppl 2):S18 doi:10.1186/bcr1816
Figure 1.
Surrogate response biomarkers will guide neoadjuvant treatment. ER, oestrogen receptor; pCR, pathological complete response; PR, progesterone receptor; Rx, treatment.
Fabian Breast Cancer Research 2007 9(Suppl 2):S18 doi:10.1186/bcr1816 |